MarketScreener Homepage > Equities > RIGA STOCK EXCHANGE,THE > Grindeks GRD1R LV0000100659

Report

Delayed RIGA STOCK EXCHANGE,THE - 01/27 08:36:38 am
13.3	EUR		-0.75%

01/26

GRINDEKS : Information about refusal to repurchase the final shares of JSC “Grindeks”

01/26

GRINDEKS : Information regarding acquisition of a major holding

01/25

GRINDEKS : Information regarding the results of mandatory redemption of shares

Summary

Quotes 5-day view Delayed Quote.

Delayed Riga Stock Exchange,the

01/21/2021	01/22/2021	01/25/2021	01/26/2021	01/27/2021	Date
13.6(c)	13.6(c)	13.45(c)	13.4(c)	13.3(c)	Last
117	376	347	369	110	Volume
+0.37%	0.00%	-1.10%	-0.37%	-0.75%	Change

More quotes

Financials

Sales 2018	145 M 176 M 176 M
Net income 2018	-9,73 M -11,8 M -11,8 M
Net Debt 2018	17,5 M 21,2 M 21,2 M
P/E ratio 2018	-6,40x
Yield 2018	19,7%

Sales 2019	141 M 171 M 171 M
Net income 2019	12,9 M 15,6 M 15,6 M
Net Debt 2019	35,0 M 42,4 M 42,4 M
P/E ratio 2019	11,0x
Yield 2019	6,22%

Capitalization	127 M 154 M 154 M
EV / Sales 2018	0,55x
EV / Sales 2019	1,25x
Nbr of Employees	1 505
Free-Float	3,22%

More Financials

Company

Grindeks is the Baltic leader pharmaceutical group. Net sales break down by activity as follows: - research, development and manufacturing of pharmaceuticals (94.9%): medicines for the treatment of cardiovascular diseases, cancers and central nervous system disorders, analgesic products, treatments of cough and flu, etc.; - production of pharmaceutical active ingredients (5.1%). Net sales break down...

Sector

Pharmaceuticals

Calendar

02/26

Earnings Release

More about the company

All news about GRINDEKS

01/26	GRINDEKS : Information about refusal to repurchase the final shares of JSC &ldqu..	AQ
01/26	GRINDEKS : Information regarding acquisition of a major holding	AQ
01/25	GRINDEKS : Information regarding the results of mandatory redemption of shares	AQ
01/05	GRINDEKS : JSC board resolution about mandatory share repurchase offer to JSC Gr..	AQ
2020	GRINDEKS : Information about mandatory offer of share repurchase	AQ
2020	GRINDEKS : Unique composition about the healing power of nature and music was cr..	PU
2020	GRINDEKS : Unique composition about the healing power of nature and music was cr..	AQ
2020	GRINDEKS : The Financial Calendar of JSC “Grindeks” for the year of ..	AQ
2020	GRINDEKS : “Grindeks” unveils new look	AQ
2020	GRINDEKS : On “Grindeks” results in the first nine months of 2020	PU
2020	GRINDEKS : On “Grindeks” results in the first nine months of 2020	AQ
2020	GRINDEKS : RESOLUTIONS of Extraordinary General Meeting of Shareholders of joint..	PU
2020	GRINDEKS : RESOLUTIONS of Extraordinary General Meeting of Shareholders of joint..	AQ
2020	GRINDEKS : Draft decision of joint stock company “GRINDEKS” Extraord..	PU
2020	GRINDEKS : Draft decision of joint stock company “GRINDEKS” Extraord..	AQ

More news

News in other languages on GRINDEKS

- No features available -

More news

Provided by Scoopnest.com

Chart GRINDEKS

Duration : Period :

Grindeks Technical Analysis Chart | GRD1R | LV0000100659 | MarketScreener

Full-screen chart

Technical analysis trends GRINDEKS

	Short Term	Mid-Term	Long Term
Trends	Bearish	Bearish	Bearish

Technical analysis

Income Statement Evolution

More Financials

Managers and Directors

Name	Title
Juris Hmelnickis	Chairman-Management Board
Kirovs Lipmans	Chairman-Supervisory Board
Janis Romanovskis	Director, Chief Financial & Administrative Officer
Eric Ivanovsky	Head-Research & Development Department
Dmitry Saikovky	Head-Technical Issues

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

GRINDEKS	-1.11%	156



OTSUKA HOLDINGS CO., LTD.	1.36%	23 531
SUN PHARMACEUTICAL INDUSTRIES LTD.	-1.00%	19 296
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO., LTD.	-7.19%	18 265
ONO PHARMACEUTICAL CO., LTD.	0.00%	15 412
DIVI'S LABORATORIES LIMITED	-7.10%	12 994

More Results